FMR LLC 13D and 13G filings for Forma Therapeutics Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-05-10 10:13 am Sale | 2022-05-09 | 13G | Forma Therapeutics Holdings, Inc. FMTX | FMR LLC | 222,990 0.492% | -3,654,062 (-94.25%) | Filing |
| 2022-02-09 09:19 am Sale | 2022-02-08 | 13G | Forma Therapeutics Holdings, Inc. FMTX | FMR LLC | 3,877,052 8.178% | -873,437 (-18.39%) | Filing |
| 2021-03-10 09:46 am Purchase | 2021-03-09 | 13G | Forma Therapeutics Holdings, Inc. FMTX | FMR LLC | 4,750,489 10.615% | 634,841 (+15.43%) | Filing |
| 2021-02-08 10:21 am Purchase | 2021-02-05 | 13G | Forma Therapeutics Holdings, Inc. FMTX | FMR LLC | 4,115,648 9.196% | 4,115,648 (New Position) | Filing |